Genotyping as a Tool to Predict Adverse Drug Reactions
Journal:
Current Topics in Medicinal Chemistry
Volume:
4
Page:
1409-1419
Author(s):
Cuneyt Guzey and Olav Spigset
Involvement of the Endocannabinoid System in Motor Disorders
Journal:
Current Medicinal Chemistry - Central Nervous System Agents
Volume:
4
Page:
175-182
Author(s):
J. J. Fernandez-Ruiz, I. Lastres-Becker, A. Cabranes, E. de Lago and J. A. Ramos
Pharmacological Aspects of (-)-Deprenyl
Journal:
Current Medicinal Chemistry
Volume:
11
Page:
2017-2031
Author(s):
K. Magyar, M. Palfi, T. Tabi, H. Kalasz, B. Szende and E. Szoko
Clinical Applications of MAO-Inhibitors
Journal:
Current Medicinal Chemistry
Volume:
11
Page:
2033-2043
Author(s):
P. Riederer, L. Lachenmayer and G. Laux
The Role of Cytochrome P450 Enzymes in the Metabolism of Risperidone and Its Clinical Relevance for Drug Interactions
Journal:
Current Drug Targets
Volume:
5
Page:
573-579
Author(s):
R. Berecz, P. Dorado, A. De La Rubia, M. C. Caceres, I. Degrell and A. LLerena
The Concept of “Neuroprotection” in Neurological Diseases
Journal:
Current Neuropharmacology
Volume:
2
Page:
261-263
Author(s):
Paolo Calabresi, Cinzia Costa, Diego Centonze, Antonio Pisani and Giorgio Bernardi
Neuroprotective Strategies for Parkinsons Disease
Journal:
Current Neuropharmacology
Volume:
2
Page:
309-322
Author(s):
Ippolita Cantuti-Castelvetri and David G. Standaert
Possible Neuroprotective Strategies for Huntingtons Disease
Journal:
Current Neuropharmacology
Volume:
2
Page:
331-342
Author(s):
James G. Greene
Drug Therapy in Schizophrenia
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
2205-2217
Author(s):
J. Ananth, S. Parameswaran and B. Hara
Antipsychotic Polypharmacy
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
2231-2238
Author(s):
J. Ananth, S. Parameswaran and Gunatilake